A previous report has shown normalization of the hormonal profile after treatment with GnRH agonist for two patients diagnosed with polycystic ovarian syndrome (PCOS) associated with 3βHSD2D [69]. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.